Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan C Grutters

Showing results (211-220 of 219) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 219 results.
Rheumatology Advances in Practice|June 10, 2024
<i>RPA3-UMAD1</i> rs12702634 and rheumatoid arthritis-associated interstitial lung disease in European ancestryPierre-Antoine Juge, Jeffrey A Sparks, Steven Gazal, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 22, 2020
Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosisFranck F Rahaghi, Robert P Baughman, Lesley Ann Saketkoo, et al.
The New England Journal of Medicine|May 19, 2025
First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or MethotrexateVivienne Kahlmann, Montse Janssen Bonás, Catharina C Moor, et al.
Respirology (Carlton, Vic.)|March 23, 2025
Lung Function Course of Patients With Pulmonary Fibrosis After Initiation of Anti-Fibrotic Treatment: Real-World Data From the Dutch National RegistryMark G J P Platenburg, Gizal Nakshbandi, Catharina C Moor, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 23, 2014
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical toolMarc A Judson, Ulrich Costabel, Marjolein Drent, et al.
The Lancet. Respiratory Medicine|May 16, 2016
Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort studySimon L F Walsh, Athol U Wells, Sujal R Desai, et al.
The Lancet. Respiratory Medicine|February 1, 2025
Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trialsJim M Smit, Philip A Van Der Zee, Sara C M Stoof, et al.
Seminars in Arthritis and Rheumatism|August 19, 2021
MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progressionPierre-Antoine Juge, Joshua J Solomon, Coline H M van Moorsel, et al.
The New England Journal of Medicine|October 23, 2018
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung DiseasePierre-Antoine Juge, Joyce S Lee, Esther Ebstein, et al.
Pageof 22

Showing results (211-220 of 219) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 219 results.
Rheumatology Advances in Practice|June 10, 2024
<i>RPA3-UMAD1</i> rs12702634 and rheumatoid arthritis-associated interstitial lung disease in European ancestryPierre-Antoine Juge, Jeffrey A Sparks, Steven Gazal, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 22, 2020
Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosisFranck F Rahaghi, Robert P Baughman, Lesley Ann Saketkoo, et al.
The New England Journal of Medicine|May 19, 2025
First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or MethotrexateVivienne Kahlmann, Montse Janssen Bonás, Catharina C Moor, et al.
Respirology (Carlton, Vic.)|March 23, 2025
Lung Function Course of Patients With Pulmonary Fibrosis After Initiation of Anti-Fibrotic Treatment: Real-World Data From the Dutch National RegistryMark G J P Platenburg, Gizal Nakshbandi, Catharina C Moor, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|April 23, 2014
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical toolMarc A Judson, Ulrich Costabel, Marjolein Drent, et al.
The Lancet. Respiratory Medicine|May 16, 2016
Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort studySimon L F Walsh, Athol U Wells, Sujal R Desai, et al.
The Lancet. Respiratory Medicine|February 1, 2025
Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trialsJim M Smit, Philip A Van Der Zee, Sara C M Stoof, et al.
Seminars in Arthritis and Rheumatism|August 19, 2021
MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progressionPierre-Antoine Juge, Joshua J Solomon, Coline H M van Moorsel, et al.
The New England Journal of Medicine|October 23, 2018
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung DiseasePierre-Antoine Juge, Joyce S Lee, Esther Ebstein, et al.
Pageof 22